Stimulatory effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on cyclic AMP formation in the hypothalamus and cerebral cortex of four avians and rat

Polish Journal of Pharmacology

Volumn 51, Issue 1, 1999, Pages 87-91

  Nowak, Jerzy Z ^a   Kuba, Katarzyna ^a   Zawilska, Jolanta B ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Brain; Chicken; Cyclic AMP; Duck; Goose; PACAP (pituitary adenylate cyclase activating polypeptide); PACAP27; PACAP38; Rat; Turkey

Indexed keywords

ADENYLATE CYCLASE; BRAIN RECEPTOR; CYCLIC AMP; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DUCK; FEMALE; FOWL; GOOSE; HYPOTHALAMUS; MALE; NONHUMAN; RAT; SPECIES DIFFERENCE; TURKEY (BIRD);

ANIMALS; CEREBRAL CORTEX; CHICKENS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DUCKS; FEMALE; GEESE; HYPOTHALAMUS; MALE; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; TURKEYS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033009368     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arimura A.: Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Peptides, 1992, 37, 287-303.
2. Arimura A.: Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol., 1998, 48, 301-331.
3. Arimura A., Shioda S.: Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front. Neuroendocrinol., 1995, 16, 53-88.
4. Chartrel N., Tonon M. C., Vaudry H., Conlon J. M.: Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary. Endocrinology, 1991, 129, 3367-3371.
5. Harmar A. J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J. R., Rawlings S. R., Robberecht P., Said S. I., Sreedharan S. P., Wank S. A., Waschek J. A.: International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev., 1998, 50, 265-270.
6. Matsuda K., Yoshida T., Nagano Y., Kashimoto K., Yatahgo T., Shimomura H., Shioda S., Arimura A., Uchiyama M.: Purification and primary structure of pituitary adenylate cyclase activating polypeptide (PACAP) from the brain of an elasmobranch, stingray, Dasyatis akajei. Peptides, 1998, 19, 1489-1495.
7. McRory J., Parker D. B., Sherwood N. M.: Expression and alternative processing of a chicken gene encoding both growth hormone-releasing hormone (GRF) and pituitary adenylate cyclase-activating peptide (PACAP). DNA Cell Biol., 1997, 16, 95-102.
8. Miyata A., Arimura A., Dahl R. R., Minamino M., Uehara A., Jiang L., Culler M. D., Coy D. H.: Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun., 1989, 164, 567-574.
9. Miyata A., Jiang L., Dahl R. D., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A.: Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun., 1990, 170, 643-648.
10. Montero M., Yon L., Rousseau K., Arimura A., Fournier A., Dufour S., Vaudry H.: Distribution, characterization, and growth hormone-releasing activity of pituitary adenylate cyclase-activating polypeptide in the european eal, Anguilla anguilla. Endocrinology, 1998, 139, 4300-4310.
11. Nowak J. Z., Sȩk B.: Stimulatory effect of histamine on cyclic AMP formation in chick pineal gland. J. Neurochem., 1994, 63, 1338-1345.
12. Nowak J. Z., Sȩk B., D'Souza T., Dryer S. E.: Does histamine stimulate cyclic AMP formation in the avian pineal gland via a novel (non-H1, non-H2, non-H3) histamine receptor subtype. Neurochem. Int., 1995, 27, 519-526.
13. Nowak J. Z., Woldan-Tambor A., Kuba K., Zawilska J. B.: A synergistic interaction between histamine and vasoactive intestinal peptide (VIP) on cyclic AMP production in the chick pineal gland. J. Physiol. Pharmacol., 1998, 49, 377-386.
14. Peeters K., Berghman L. R., Vandesande F.: Comparative distribution of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide immunoreactivity in the chicken forebrain. Ann. NY Acad. Sci., 1998, 839, 417-419.
15. Rawlings S. R., Hezareh M.: Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/ vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocrine Rev., 1996, 17, 4-29.
16. Salomon Y., Londos C., Rodbell M.: A highly sensitive adenylate cyclase assay. Anal. Biochem., 1974, 58, 541-548.
17. Shimizu H., Daly J. W., Creveling C. R.: A radioisotopic method for measuring the formation of adenosine 3′,5′-cyclic monophosphate in incubated slices of brain. J. Neurochem., 1969, 16, 1609-1619.
18. Wong A. O. L., Leung M. Y., Shea W. L. C., Tse L. Y., Chang J. P., Chow B. K. C.: Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Endocrinology, 1998, 139, 3465-3479.
19. Yon L., Feuilloley M., Chartrel N., Arimura A., Conlon J. M., Fournier A., Vaudry H., Immunohistochemical distributión and biological activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the central nervous system of the frog Rana ridibunda. J. Comp. Neurol., 1992, 324, 485-499.